RAMAT GAN, ISRAEL, Jan. 29, 2026 (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (Nasdaq:XTLB) (TASE:XTLB.TA) (the “Company” or “XTL”), announced that it is working diligently to close the acquisition ...
XTL Biopharmaceuticals Ltd. (NASDAQ:XTLB) announced Wednesday that it is proceeding with the acquisition of 85% of NeuroNOS Ltd. from Beyond Air Inc., following a binding letter of intent signed on ...
The Bowflex T6, T9, and T16 share the same smooth MaxReact motor and plush, joint-friendly FlexZone cushioning—ideal for real-world home workouts. The T16 is the star: a powerhouse with a cinematic ...
RAMAT GAN, ISRAEL, Jan. 23, 2026 (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (Nasdaq:XTLB) (TASE:XTLB.TA) (the “Company” or “XTL”), announced today that it has received a notification letter from ...
Beyond Air (NASDAQ: XAIR), majority owner of NeuroNOS, to hold 19.99% of XTL's post-transaction share capital Beyond Air to receive up to $32.5 million in upfront, development and commercial milestone ...
The consideration includes 19.9% of XTL's issued shares, $1 million in cash, and milestone-based contingent payments of up to $32.5 million. The transaction remains subject to customary closing ...
Launched on 01/26/2011, the State Street SPDR S&P Telecom ETF (XTL) is a smart beta exchange traded fund offering broad exposure to the Communication Services ETFs category of the market. What Are ...
State Street® SPDR® S&P® Telecom ETF is upgraded to Buy for 2026, reflecting its evolution into a growth-focused, small/mid-cap telecom and AI infrastructure portfolio. XTL’s 2025 total return neared ...
Welcome to “Today in Gear,” your daily snapshot of the most important releases in style, watches, tech, motoring, fitness, home and the outdoors. Today in Gear: The most important news in the product ...